s6y
Company name or ticker
Search
Oruka Therapeutics, Inc.
8-K
Current report filing
Filed
Monday, August 21, 2017
Period
Aug 21, 2017
Accession number
0001193125-17-263720
Documents
8-K
8-K
EX-5.1
EX-5.1
EX-10.1
EX-10.1
On sec.gov
Filing index
All files
Complete submission text
SGML header